معرفی
Professor Hang Ta is a leading academic at Griffith University, holding positions in the School of Environment and Science (Bioscience Department). As an ARC Future Fellow and Heart Foundation Future Leader Fellow, she specializes in bio-nanomaterials for diagnosing and treating cardiovascular diseases, cancer, and blood disorders. Her research emphasizes innovative nanomaterials, MRI nanosensors, and microfluidic devices for disease modeling and drug discovery. With $5.2M in grant funding and over 117 publications, her work is published in high-impact journals like Nature Protocols and Circulation Research. She leads a team of 12 students and 2 postdocs, and serves on the ARC College of Experts and editorial boards. Key achievements include developing theranostic nanoparticles, atherosclerosis-on-chip models, and anti-VCAM-1 therapies.
Research Interests: Her work spans nanomedicine, cardiovascular disease therapies, targeted drug delivery, and microfluidic platforms for disease modeling. She focuses on translating nanomaterials into clinical applications for thrombosis, cancer, and inflammatory diseases.
- Grants & Awards: ARC Future Fellowship, NHMRC ECR Fellowship, Heart Foundation Fellowships, and $5.2M in competitive grants.
- Collaborations: Partnerships with institutions like the University of Queensland, Monash University, and international universities in Vietnam, Germany, and China.
- Professional Roles: Editor for journals like Circulation Research and reviewer for national/international funding bodies (ARC, NHMRC).
Lab & Teams: Her lab develops advanced biomaterials and microfluidic systems, with a focus on translational research for clinical impact.
